Bevicra 400mg Injection contains bevacizumab, a monoclonal antibody medicine used to treat various advanced cancers including metastatic cancer of the colon and rectum, metastatic breast cancer, non‑small cell lung cancer, kidney cancer, recurrent epithelial ovarian cancer, fallopian tube and primary peritoneal cancer, and persistent, recurrent, or metastatic cervical cancer. It works by blocking vascular endothelial growth factor (VEGF), a protein that stimulates the growth of new blood vessels that supply oxygen and nutrients to tumour cells, thereby slowing tumour growth and spread when used as part of a combination cancer treatment. Your doctor will explain why it is suitable for you.

Bevicra 400mg Injection is given by a healthcare professional as an intravenous infusion into a vein. Your doctor will decide the correct dose and duration based on your cancer type, body weight, and treatment response. It should only be administered under medical supervision in a hospital or clinic setting.

Common side effects may include constipation, loss of appetite, fever, nosebleeds, changes in taste or speech, dry skin, increased tear production, back pain, and runny nose. More serious side effects can occur, such as high blood pressure, reduced white blood cell counts leading to increased infection risk, clotting disorders, severe abdominal pain, bleeding, and problems with wound healing. Contact your doctor immediately if you notice symptoms such as severe bleeding, difficulty breathing, sudden chest pain, severe weakness, or signs of a serious allergic reaction.

You can obtain Bevicra 400mg Injection from licensed pharmacies with a valid prescription. Contact Macarius Health to check availability and pricing.

Store Bevicra 400mg Injection under refrigerated conditions between 2°C and 8°C. Do not freeze. Keep the medicine in its original packaging protected from light and out of reach of children and pets.

Tell your doctor about all other medicines, supplements, or herbal products you are taking. Some medicines may interact with bevacizumab or increase the risk of side effects such as bleeding, blood clots, or impaired wound healing. Your doctor may adjust your treatment or monitoring accordingly.

Bevicra 400mg Injection is not recommended during pregnancy or while breastfeeding, as it may cause harm to the unborn baby or infant. Women of childbearing potential should use effective contraception during treatment and for a period after the last dose. Discuss any concerns with your doctor.

Delivery time depends on stock availability and location. Macarius Health arranges prompt delivery within Delhi NCR. For other cities across India, delivery typically follows standard courier timelines.